What is Quiver Bioscience?
Quiver Bioscience operates at the intersection of biotechnology and computational engineering, dedicated to decoding the complexities of the human brain. The company utilizes a multi-disciplinary approach that integrates scalable human models with proprietary AI-driven analytics to uncover biological insights that were previously inaccessible. By mapping neuronal activity with unprecedented precision, Quiver Bioscience is effectively bridging the gap between raw biological data and actionable therapeutic candidates. Their platform serves as a foundational technology for modern drug discovery, enabling the identification of effective molecules that address unmet needs in neurological health. Through the synthesis of advanced imaging and surrogate AI models, the firm is redefining the standard for target validation and candidate selection in the biotech sector.
How much funding has Quiver Bioscience raised?
Quiver Bioscience has raised a total of $2M across 1 funding round:
Grant
$2M
Grant (2025): $2M with participation from National Institutes of Health (NIH
Key Investors in Quiver Bioscience
National Institutes of Health (NIH)
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, providing critical support for high-impact scientific innovation.
What's next for Quiver Bioscience?
With the successful closure of this major enterprise-level funding, Quiver Bioscience is poised to scale its operational capacity and expand its research pipeline. The strategic focus will likely shift toward the clinical validation of its lead candidates and the further refinement of its Genomic Positioning System. As the company matures, the integration of additional multi-omics datasets will be paramount to maintaining its competitive edge in the neuro-pharmacology space. Investors and industry observers will be monitoring the firm's ability to translate its computational insights into tangible clinical outcomes, a move that could establish Quiver Bioscience as a dominant force in the next generation of brain-focused medicine.
See full Quiver Bioscience company page
